How many drugs treat Testicular Germ Cell Tumor?

Drug Landscape tracks 7 marketed treatments for Testicular Germ Cell Tumor (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/testicular-germ-cell-tumor.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Testicular Germ Cell Tumor — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testicular Germ Cell Tumor (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Testicular Germ Cell Tumor, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Ifex	IFOSFAMIDE	Baxter	Alkylating Drug [EPC]		1988-01-01
Mesnex	MESNA	Baxter	mesna		1988-01-01
Platinol-Aq	cisplatin	Pfizer	Platinum-based Drug [EPC]	D(3) dopamine receptor	1978-01-01
Blenoxane	BLEOMYCIN	Bristol-Myers Squibb	Cytoprotective Agent	Aspartyl/asparaginyl beta-hydroxylase	1973-01-01
Ifosfamid	Ifosfamid	Polish Lymphoma Research Group
IFO	IFO	Italian Sarcoma Group	Alkylating Agent	DNA
Isophosphamide	Isophosphamide	Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Baxter · 2 drugs in Testicular Germ Cell Tumor
Bristol-Myers Squibb · 1 drug in Testicular Germ Cell Tumor
Italian Sarcoma Group · 1 drug in Testicular Germ Cell Tumor
Pfizer · 1 drug in Testicular Germ Cell Tumor
Polish Lymphoma Research Group · 1 drug in Testicular Germ Cell Tumor
Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 drug in Testicular Germ Cell Tumor

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Testicular Germ Cell Tumor:

Cite this brief

Drug Landscape (2026). Testicular Germ Cell Tumor — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/testicular-germ-cell-tumor. Accessed 2026-06-10.

Testicular Germ Cell Tumor full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing